Alzheimer's Disease Research Center (ADRC), University of Washington

Welcome

The UW Alzheimer’s Disease Research Center (ADRC) is one of a nationwide network of 30 research resource centers funded by the National Institute on Aging. ADRCs are major sources of discovery into the nature of Alzheimer’s disease and related dementias and into the development of more effective approaches to prevention, diagnosis, care, and therapy. The UW ADRC contributes to the development of shared resources that support dementia-relevant research, and coordinates research efforts with other NIH-funded programs and investigators. UW ADRC resources are designed to facilitate and empower related research efforts at UW.

The UW ADRC is closely affiliated with the UW Memory and Brain Wellness Center clinic and links the Seattle community with information and opportunities to participate in studies of Alzheimer’s disease and related disorders (Lewy Body dementia, and frontotemporal degeneration, and vascular dementia). Our busy outreach team is influential in promoting strengths-based reframing of Alzheimer’s disease and dementia-friendly communities, and they organize and promote educational public talks and events and research seminars. We support outreach and culturally adapted Alzheimer’s disease programs for Indigenous communities and clinics. Join us!

Director: Dr. Thomas J. Grabowski, MD
Program Manager: Annika Noreen, PhD, PMP

Announcements

Learn more about using ADC Biospecimen Research Resources

November 12, 2019 — Webinar: “Introduction to the NCRAD Biospecimens Online Catalog” on Monday, November 18 at 1-2pm PST. For more info & RSVP, click below.


Alzheimer’s Disease Genetics Symposium November 12-13, 2019 Philadelphia, PA

October 31, 2019 — The ADRC's Dr. Brian Kraemer, PhD, will be presenting at the session titled Functional AD genomics and Validation of regulatory noncoding variants. Please find the full agenda at the link.


The AFTD and Target ALS Launch a $5M grant initiative to search for FTD-ALS biomarkers and treatments

October 15, 2019 — Together with the Association for Frontotemporal Degeneration, Target ALS just launched a $5M grant-making initiative to bring scientists together in search of biomarkers and treatment options for FTD and ALS. Call for proposals in link.

Upcoming Research Events

Loading...

Loading...